Arma Partners is pleased to announce that it has acted as financial advisor to Eagle Genomics on its growth capital raise. The round is led by abrdn plc alongside returning investor Environmental Technologies Fund, and a consortium of investors headed by Granpool Innovative Investments.

Eagle Genomics is pioneering the application of network science to biological discovery and innovation, across the Food and Nutrition, AgBio, Beauty and Personal Care, and Biopharma industries. Its purpose is to accelerate the Bioeconomy through the digital reinvention of life sciences R&D. The investment will support further development of Eagle Genomics’ platform, drive expansion into global markets and enable further deepening of client impact.

The transaction underlines the capabilities of Arma Partners’ Private Capital practice navigating the private fundraising markets to achieve successful transaction outcomes for industry disrupting businesses. The transaction further highlights Arma Partners’ unique and growing expertise in DeepTech and our ongoing commitment to technologies that enable the United Nations’ Sustainable Development Goals.